News | Artificial Intelligence | February 07, 2018

NEST Program Names ACR Data Science Institute AI Use Case as Demonstration Project

Designation boosts national efforts to improve medical imaging care using artificial intelligence

NEST Program Names ACR Data Science Institute AI Use Case as Demonstration Project

February 7, 2018 — A U.S. Food and Drug Administration (FDA)-funded program to speed safe and effective medical device technologies to market has chosen an ACR Data Science Institute (DSI) use case among its first demonstration projects.

The National Evaluation System for Health Technology Coordinating Center (NESTcc) selected the “Lung-RADS Assist: Advanced Radiology Guidance, Reporting and Monitoring” use case. The center supports timely, reliable and cost-effective evidence development regarding FDA medical device pre- and post-market requirements.

“We are proud that the NEST program recognizes the value of the ACR Data Science Institute’s groundbreaking work. The ACR DSI will employ our open framework, TOUCH-AI (Technology Oriented Use Cases for Healthcare Artificial Intelligence), to provide infrastructure for ongoing longitudinal AI algorithm verification pre- and post-FDA approval. This can help bring better medical care to patients more quickly,” said ACR DSI Chief Medical Officer Bibb Allen Jr., M.D., FACR.  

Lung-RADS Assist will determine the end-to-end workflow from deployment of an AI algorithm in a radiology reporting system through capture of performance metrics within a national registry. It will:

  • Utilize existing ACR technology to demonstrate the ability to collect validation data and perform local algorithm testing prior to market approval;
  • Utilize existing ACR technology to facilitate interoperability between reporting and AI vendors to generate standardized data in a real-world setting; and
  • Capture validation data and real-world events in a national registry to enable both facility-level and cross-facility reporting.

“The future of medical imaging is doctors harnessing the power of AI to enhance their decision making. New and existing technologies will provide greater detection and treatment by using all available data to improve patient -centered care. The ACR DSI provides a national foundation to move this process forward,” said Keith J. Dreyer, DO, Ph.D., FACR, ACR DSI chief science officer.

Use cases are clinical scenarios in which artificial intelligence (AI) use may improve care. Defining these cases is a first step in the creation of AI algorithms to answer primary clinical questions in each case. Medical imaging AI use case development is an initial focus of the ACR DSI. The DSI was launched in May 2017 to develop and use AI to help radiologists improve medical imaging care.

The first NESTcc demonstration projects will develop, verify and operationalize methods of evidence generation and data use. The projects will build out critical functions and processes to sustain the NEST program.

For more information: www.nestcc.org

 

Related Content

Body Vision Medical Announces Release of LungVision
Technology | Lung Cancer | October 05, 2018
Body Vision Medical, a medical device company specializing in lung cancer diagnostics, announced the launch of its...
Adherence to Annual Lung Cancer Screening Needs Improvement
News | Lung Cancer | October 03, 2018
A study of adherence to annual low-dose computed tomography (LDCT) screening within the Veteran Health Administration...
Augusta University Streamlines Lung Cancer Diagnosis With Hybrid Operating Room

Carsten Schroeder, M.D., thoracic surgical oncologist at the Georgia Cancer Center and Medical College of Georgia at Augusta University in the hybrid OR. Image courtesy of Phil Jones, Senior Photographer, Augusta University

News | Lung Cancer | September 26, 2018
September 26, 2018 — When it comes to surviving cancer, early detection and treatment could be the key to a patient's
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
RSNA Announces Pneumonia Detection Machine Learning Challenge
News | Artificial Intelligence | August 27, 2018
The Radiological Society of North America (RSNA) has launched its second annual machine learning challenge. The RSNA...
Doctor-Patient Discussions Neglect Potential Harms of Lung Cancer Screening
News | Lung Cancer | August 15, 2018
August 15, 2018 — Although national guidelines advise doctors to discuss the benefits and harms of...
Metro Health-University of Michigan Health Partners With Eon to Improve Lung Cancer Care
News | Oncology Diagnostics | August 07, 2018
Metro Health-University of Michigan Health announced it is partnering with healthcare data company Eon to improve the...
Study Shows Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers
News | Lung Cancer | July 16, 2018
A four-protein biomarker blood test improves lung cancer risk assessment over existing guidelines that rely solely upon...
Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...